- Home
- PLX vs REI Comparison
PLX vs REI Comparison
Compare PLX & REI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLX | REI |
|---|---|---|
| Founded | 1993 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.0M | 181.3M |
| IPO Year | 1996 | 2013 |
Fundamental Metrics
Financial Performance| Metric | PLX | REI |
|---|---|---|
| Price | $2.15 | $1.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 660.7K | ★ 4.5M |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $52,744,000.00 | ★ $307,178,072.00 |
| Revenue This Year | $36.81 | N/A |
| Revenue Next Year | N/A | $10.17 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.34 | $0.72 |
| 52 Week High | $3.19 | $1.65 |
Technical Indicators
Market Signals| Indicator | PLX | REI |
|---|---|---|
| Relative Strength Index (RSI) | 38.82 | 64.36 |
| Support Level | $2.03 | $1.21 |
| Resistance Level | $2.42 | N/A |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 10.91 | 98.91 |
Price Performance
Historical ComparisonAbout PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About REI Ring Energy Inc.
Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform and the Delaware Basin all of which are part of the Permian Basin in Texas.